42301 Efficacy and safety of clascoterone cream 1% in patients with acne vulgaris across subgroups defined by demographic characteristics

Lawrence F. Eichenfield,Adelaide A. Hebert,Diane Thiboutot,Linda Stein Gold,Martina Cartwright,Luigi Moro, Jenny Han,Nicholas Squittieri,Alessandro Mazzetti

Journal of The American Academy of Dermatology（2023）

引用 0|浏览4

暂无评分

摘要

Introduction: Clascoterone cream 1% is approved for the treatment of acne vulgaris in patients aged ≥12 years. Pooled data analyses stratified by age and sex from two Phase 3 studies [1] and a long-term extension study [2] are presented.

查看译文

关键词

acne vulgaris,clascoterone cream

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要